| 2021-04-14 | Medpace Investors, LLC | 10% Owner | Sell | 3,720 | $180.48 | $671,385.60 | - | → |
| 2021-04-14 | EWALD STEPHEN P | General Counsel & Corp. Secy. | Sale+OE | 1,200 | $180.67 | $216,804.00 | -8.0% | → |
| 2021-04-14 | Troendle August J. | President & CEO | Sell | 3,720 | $180.48 | $671,385.60 | - | → |
| 2021-04-14 | GEIGER JESSE J | CFO & COO, Lab Operations | Sale+OE | 3,000 | $180.00 | $540,000.00 | -32.0% | → |
| 2021-03-03 | BURWIG SUSAN E | Exec. VP, Operations | Sell | 6,211 | $167.00 | $1,037,237.00 | -8.1% | → |
| 2021-02-10 | GEIGER JESSE J | CFO & COO, Lab Operations | Sale+OE | 4,000 | $160.00 | $640,000.00 | -38.5% | → |
| 2021-02-09 | EWALD STEPHEN P | General Counsel & Corp. Secy. | Sale+OE | 10,000 | $155.48 | $1,554,800.00 | -41.9% | → |
| 2021-01-08 | Medpace Investors, LLC | - | Sell | 26,666 | $140.71 | $3,752,172.86 | -0.4% | → |
| 2021-01-08 | Troendle August J. | President & CEO | Sell | 26,666 | $140.71 | $3,752,172.86 | -0.4% | → |
| 2021-01-07 | Medpace Investors, LLC | - | Sell | 185,219 | $140.06 | $25,941,773.14 | -1.4% | → |
| 2021-01-07 | Troendle August J. | President & CEO | Sell | 185,219 | $140.06 | $25,941,773.14 | -1.4% | → |
| 2021-01-04 | Medpace Investors, LLC | - | Sell | 10,127 | $140.01 | $1,417,881.27 | -0.2% | → |
| 2021-01-04 | Troendle August J. | President & CEO | Sell | 10,127 | $140.01 | $1,417,881.27 | -0.2% | → |
| 2020-12-30 | Troendle August J. | President & CEO | Sell | 19,930 | $140.01 | $2,790,399.30 | -0.3% | → |
| 2020-12-30 | Medpace Investors, LLC | - | Sell | 19,930 | $140.01 | $2,790,399.30 | -0.3% | → |
| 2020-12-28 | Troendle August J. | President & CEO | Sale+OE | 8,750 | $140.04 | $1,225,390.17 | - | → |
| 2020-12-28 | Medpace Investors, LLC | - | Sell | 8,750 | $140.04 | $1,225,390.17 | - | → |
| 2020-12-22 | Troendle August J. | President & CEO | Sell | 33,260 | $140.01 | $4,656,732.60 | -0.5% | → |
| 2020-12-22 | Medpace Investors, LLC | 10% Owner | Sell | 33,260 | $140.01 | $4,656,732.60 | -0.5% | → |
| 2020-12-18 | Troendle August J. | President & CEO | Sell | 216,048 | $141.85 | $30,646,408.80 | -3.2% | → |
| 2020-12-18 | Medpace Investors, LLC | 10% Owner | Sell | 216,048 | $141.85 | $30,646,408.80 | -3.2% | → |
| 2020-12-14 | GEIGER JESSE J | CFO & COO, Lab Operations | Sale+OE | 4,200 | $142.00 | $596,400.00 | -39.7% | → |
| 2020-12-10 | EWALD STEPHEN P | General Counsel & Corp. Secy. | Sale+OE | 10,000 | $140.07 | $1,400,700.00 | -41.9% | → |
| 2020-12-01 | Medpace Investors, LLC | - | Sell | 14,000 | $130.86 | $1,832,040.00 | -0.2% | → |
| 2020-12-01 | Troendle August J. | President & CEO | Sell | 14,000 | $130.86 | $1,832,040.00 | -0.2% | → |
| 2020-09-01 | GEIGER JESSE J | CFO & COO, Lab Operations | Sale+OE | 6,810 | $130.00 | $885,300.00 | -34.8% | → |
| 2020-08-27 | Medpace Investors, LLC | - | Sell | 15,923 | $123.33 | $1,963,734.13 | -0.1% | → |
| 2020-08-27 | Troendle August J. | President & CEO | Sell | 15,923 | $123.33 | $1,963,734.13 | -0.1% | → |
| 2020-08-25 | Troendle August J. | President & CEO | Sell | 30,500 | $123.31 | $3,760,972.39 | -0.2% | → |
| 2020-08-25 | Medpace Investors, LLC | - | Sell | 30,500 | $123.31 | $3,760,972.39 | -0.2% | → |
| 2020-08-21 | Medpace Investors, LLC | - | Sell | 43,117 | $125.01 | $5,389,928.27 | -0.3% | → |
| 2020-08-21 | Troendle August J. | President & CEO | Sell | 43,117 | $125.01 | $5,389,928.27 | -0.3% | → |
| 2020-08-19 | Troendle August J. | President & CEO | Sell | 38,203 | $127.47 | $4,869,710.96 | -0.3% | → |
| 2020-08-19 | Medpace Investors, LLC | - | Sell | 38,203 | $127.47 | $4,869,710.96 | -0.3% | → |
| 2020-08-17 | GEIGER JESSE J | CFO & COO, Lab Operations | Sale+OE | 3,500 | $128.00 | $448,000.00 | -35.4% | → |